Neurocrine Biosciences (NBIX) Fails to deliver data

Key failure to deliver metrics for Neurocrine Biosciences :

• Last SEC data release: 2025-01-31
• Last 15 days FTD volume: C$0.99 M
• Last 3 months FTD volume: C$4.27 M
• Last year FTD volume: C$4.27 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Neurocrine Biosciences (NBIX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Neurocrine Biosciences (NBIX) - since 2013

Neurocrine Biosciences (NBIX) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Repligen RGEN	C$1.63 M	C$32.44 M	🇺🇸 USA
Royalty Pharma RPRX	C$21.96 M	C$30.67 M	🇬🇧 UK
Palatin Technologies PTN	C$1.86 M	C$3.93 M	🇺🇸 USA
Eli Lilly LLY	C$85.36 M	C$0.21 B	🇺🇸 USA
AbbVie ABBV	C$50.09 M	C$0.20 B	🇺🇸 USA
Pfizer PFE	C$21.73 M	C$0.33 B	🇺🇸 USA
ANI Pharmaceuticals ANIP	C$2.29 M	C$4.44 M	🇺🇸 USA
Athersys ATHX	C$0.09 M	C$0.71 M	🇺🇸 USA